Kevin C Soares,Lei Zheng,Barish Edil et al.
Kevin C Soares et al.
Pancreatic ductal adenocarcinoma (PDA) remains a highly lethal disease; new therapeutic modalities are urgently needed. A number of immunotherapies tested in preclinical models have shown promise. Early-phase clinical trials have demonstrat...
Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer [0.03%]
胰腺癌姑息化疗及其他支持手段
Kevin M Sullivan,Peter S Kozuch
Kevin M Sullivan
Metastatic pancreatic cancer is a devastating disease with a dismal prognosis. Gemcitabine chemotherapy has been the mainstay of treatment for many years. Efforts to improve survival outcomes with gemcitabine-based combination chemotherapy ...
Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma [0.03%]
术前放疗辅助治疗 periampullary 胰腺癌的概念演变
Ross Allen Abrams
Ross Allen Abrams
Presently, many oncologists feel that radiotherapy should not be part of curative intent, adjuvant management for pancreatic adenocarcinoma ("pancreatic cancer"). Historically, among oncologists who provided adjuvant therapy in this context...
Brandon G Smaglo,Michael J Pishvaian
Brandon G Smaglo
Chemotherapy is proven to play a central role in the adjuvant management of pancreatic cancer. A number of studies have validated its small but significant survival benefit to patients following surgical resection, but many questions about ...
Postresection surveillance for pancreatic cancer performance status, imaging, and serum markers [0.03%]
胰腺癌术后监测:体能状态、影像学和血清标志物
Eileen M OReilly,Maeve A Lowery
Eileen M OReilly
Approximately 15% of patients with a diagnosis of pancreatic adenocarcinoma are candidates for potentially curative surgery. However, most patients who undergo such surgery will die from recurrent disease, most within the first few years, w...
A neoadjuvant strategy for the management of nonmetastatic pancreatic cancer [0.03%]
非转移性胰腺癌的新辅助治疗策略
Stephanie L Goff,John A Chabot
Stephanie L Goff
Treatment of pancreatic cancer has become increasingly multimodal, with patients undergoing chemotherapy, radiation, and surgical extirpation in hope of long-term cures. There is ongoing debate over the timing, sequence, and necessity of th...
Daniel B Brown,Govindarajan Narayanan
Daniel B Brown
Patients with pancreatic cancer have a dismal prognosis. This article reviews the role that interventional radiology can play in managing postoperative complications and in patient palliation, particularly with an obstructed biliary system....
Gregory A Coté,Stuart Sherman
Gregory A Coté
Endoscopy has an increasingly important role in the palliation of patients with pancreatic ductal adenocarcinoma. Endoscopic biliary drainage is still requested in the majority of patients who present with obstructive jaundice, and the incr...
Claudius Conrad,Keith D Lillemoe
Claudius Conrad
The surgical palliation of pancreatic cancer remains an important component of the treatment of this disease. The introduction of a new aggressive and effective chemotherapy regimen (FOLFIRINOX), interdisciplinary palliative care, and minim...
Michael L Kendrick
Michael L Kendrick
Minimally invasive surgical approaches for pancreatic resection have been established as feasible and safe. Whereas widespread application of laparoscopic distal pancreatectomy is in progress, the utilization of laparoscopic pancreaticoduod...